243 related articles for article (PubMed ID: 31047150)
1. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
Willeman T; Jourdil JF; Gautier-Veyret E; Bonaz B; Stanke-Labesque F
Anal Chim Acta; 2019 Aug; 1067():63-70. PubMed ID: 31047150
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Jourdil JF; Némoz B; Gautier-Veyret E; Romero C; Stanke-Labesque F
Ther Drug Monit; 2018 Aug; 40(4):417-424. PubMed ID: 29608486
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
El Amrani M; Bosman SM; Egas AC; Hack CE; Huitema ADR; van Maarseveen EM
Ther Drug Monit; 2019 Oct; 41(5):640-647. PubMed ID: 31584927
[TBL] [Abstract][Full Text] [Related]
5. Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
Assa A; Matar M; Turner D; Broide E; Weiss B; Ledder O; Guz-Mark A; Rinawi F; Cohen S; Topf-Olivestone C; Shaoul R; Yerushalmi B; Shamir R
Gastroenterology; 2019 Oct; 157(4):985-996.e2. PubMed ID: 31194979
[TBL] [Abstract][Full Text] [Related]
6. Rapid and simultaneous quantification of a mixture of biopharmaceuticals by a liquid chromatography/quadrupole time-of-flight mass spectrometric method in rat plasma following cassette-dosing.
Park MH; Byeon JJ; Shin SH; Kim N; Park Y; Ill Lee B; Choi J; Shin YG
Rapid Commun Mass Spectrom; 2018 Jun; 32(11):889-896. PubMed ID: 29578307
[TBL] [Abstract][Full Text] [Related]
7. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry.
Amrani ME; Gerencser L; Huitema ADR; Hack CE; van Luin M; van der Elst KCM
J Chromatogr A; 2021 Oct; 1655():462489. PubMed ID: 34509691
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a targeted affinity-enrichment and LC-MS/MS proteomics approach for the therapeutic monitoring of adalimumab.
Yang Y; Wysocki E; Antwi K; Niederkofler E; Leung EKY; Lazar-Molnar E; Yeo KJ
Clin Chim Acta; 2018 Aug; 483():308-314. PubMed ID: 29752913
[TBL] [Abstract][Full Text] [Related]
9. Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion.
Chiu HH; Tsai YJ; Lo C; Lin CH; Tsai IL; Kuo CH
Anal Chim Acta; 2022 Feb; 1193():339319. PubMed ID: 35058007
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease.
Bodini G; Giannini EG; Savarino V; Del Nero L; Pellegatta G; De Maria C; Baldissarro I; Savarino E
Scand J Gastroenterol; 2016 Sep; 51(9):1081-6. PubMed ID: 27207330
[TBL] [Abstract][Full Text] [Related]
11. Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS.
Chiu HH; Liao HW; Shao YY; Lu YS; Lin CH; Tsai IL; Kuo CH
Anal Chim Acta; 2018 Aug; 1019():93-102. PubMed ID: 29625688
[TBL] [Abstract][Full Text] [Related]
12. Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle.
Amrani ME; van der Elst KCM; Huitema ADR; van Luin M
J Chromatogr A; 2022 Feb; 1665():462840. PubMed ID: 35121176
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease.
Bian S; Lu J; Delport F; Vermeire S; Spasic D; Lammertyn J; Gils A
Drug Test Anal; 2018 Mar; 10(3):592-596. PubMed ID: 28743169
[TBL] [Abstract][Full Text] [Related]
14. Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods.
Tron C; Lemaitre F; Bros P; Goulvestre C; Franck B; Mouton N; Bagnos S; Coriat R; Khoudour N; Lebert D; Blanchet B
Bioanalysis; 2022 Jun; 14(11):831-844. PubMed ID: 35735172
[No Abstract] [Full Text] [Related]
15. Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients.
Truffot A; Jourdil JF; Veyret-Gautier E; Noble J; Jouve T; Malvezzi P; Rostaing L; Stanke-Labesque F
Clin Biochem; 2023 Mar; 113():17-20. PubMed ID: 36586569
[TBL] [Abstract][Full Text] [Related]
16. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
[TBL] [Abstract][Full Text] [Related]
17. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Drug Monitoring Guides the Management of Crohn's Patients with Secondary Loss of Response to Adalimumab.
Restellini S; Chao CY; Lakatos PL; Aruljothy A; Aziz H; Kherad O; Bitton A; Wild G; Afif W; Bessissow T
Inflamm Bowel Dis; 2018 Jun; 24(7):1531-1538. PubMed ID: 29668893
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
Vande Casteele N; Baert F; Bian S; Dreesen E; Compernolle G; Van Assche G; Ferrante M; Vermeire S; Gils A
J Crohns Colitis; 2019 Sep; 13(10):1248-1256. PubMed ID: 30820530
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
